Central serous chorioretinopathy is a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local administration of corticosteroids via inhaled and intranasal, epidural, intra-articular, topical dermal, and periocular routes.
Advice for healthcare professionals:
- advise patients to report any blurred vision or other visual disturbances during corticosteroid treatment
- consider referral to an ophthalmologist for evaluation of possible causes if a patient presents with vision problems
- report suspected adverse reactions to us on a Yellow Card
Please see the MHRA Drug Safety Update website for more information.